Skip to main content
Premium Trial:

Request an Annual Quote

GovernmentAfter Review, DOE’s GTL Shifts Plans, Scraps Grant request

Premium

The Department of Energy’s Office of Science has restructured the facilities plan for its Genomics: Genomes to Life program in response to a review by the National Research Council of the National Academies.

Rather than creating four separate facilities devoted specifically to protein production, biomolecular imaging, proteomics, and systems biology, as it had earlier planned, GTL now envisions “one or two vertically integrated centers with a focus on bioenergy research,” according to DOE. However, the agency says it could consider building centers for systems biology research into carbon sequestration and bioremediation in future years.

Additionally, DOE canceled its funding opportunity announcement for a planned GTL facility for the production and characterization of proteins and molecular tags, issued in early January. DOE says it plans to issue a new solicitation in the coming months for one or more centers for bioenergy research, and that such research has become an increasing priority for GTL.

The changes follow on the heels of a non-binding review by NRC that recommended GTL uproot its R&D plan of creating the four technology-specific centers in favor of building four vertically integrated facilities in which the four original disciplines would look for applications for tasks already identified as GTL targets.

“We’re recommending a biology-oriented, programmatic approach rather than just building large-scale facilities around innovative technologies,” says Charles Cantor, chief science officer at Sequenom and one of 12 co-authors of the NRC report. “It’s safe to assume that the investment in technologies probably doesn’t have to be as large as DOE had previously projected.”

According to the NRC report, it would’ve taken 24 years for DOE’s technology-specific facilities to be built and “to reach full capabilities.” NRC suggested instead that DOE center the facilities around energy alternatives, legacy waste solutions, and carbon sequestration.

David Kingsbury of the Gordon & Betty Moore Foundation and a report co-author says the reconfiguration would help keep the program dynamic and timely. “There is an opportunity for a broader number of vendors to be engaged early on,” he says. “From sequencing to protein production to imagery and mass spectrometry, there is a lot of potential. DOE will be making an investment and making sure they stay state-of-the-art.”

— Elizabeth Kiem and Justin Petrone

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.